Table 3.
Study time (min) | CO2 (%) | CH3ONO2 (pptv) | Toluene (pptv) | 2-PeONO2 (pptv) | Butanone (pptv) | 2-Pentanone (pptv) | MTBE (pptv) |
---|---|---|---|---|---|---|---|
Study 1: glucose infusion (n = 17) | |||||||
30–60 | 4.81 ± 0.08 | 13.9 ± 3.1 | −99±272 | −2.09 ± 0.20 | 7573 ± 3274 | 6234 ± 1457 | 5562 ± 1302 |
130–150 | 4.62 ± 0.09 | 10.0 ± 1.8 | −101 ± 168 | −3.40 ± 0.32 | 8608 ± 3083 | 3993 ± 846 | 1975 ± 414 |
220–240 | 4.78 ± 0.08 | 7.7 ± 1.5 | 96 ± 191 | −4.39 ± 0.38 | 13,762 ± 3525 | 2584 ± 869 | 2341 ± 561 |
Study 2: lipid infusion (n = 15) | |||||||
---|---|---|---|---|---|---|---|
30–60 | 4.45 ± 0.12 | 9.0 ± 1.9 | −257 ± 64 | −1.95 ± 0.39 | 13,871 ± 5903 | 6769 ± 1214 | 1855 ± 363 |
130–150 | 4.62 ± 0.11 | 7.3 ± 1.3 | −123 ± 73 | −2.78 ± 0.44 | 18,916 ± 2966 | 10,882 ± 1443 | 1083 ± 175 |
220–240 | 4.41 ± 0.11 | 5.7 ± 1.1 | 20 ± 49 | −2.58 ± 0.54 | 32,391 ± 8103 | 16,964 ± 2272 | 877 ± 135 |